Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study

China-Japan Friendship Hospital7,600 enrolled

Overview

The purpose of this study is to investigate the demographic characteristics, clinical features, diagnoses and treatments of AECOPD hospitalized patients in China, and disease prognosis and its economic burden.

Study Type

OBSERVATIONAL

Enrollment

7,600

Conditions

Chronic Obstructive Pulmonary Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: ≥18 years of age; hospitalized patients with main diagnosis as AECOPD. Exclusion Criteria: Patients diagnosed as active pulmonary tuberculosis, or acute left heart failure; Patients participating in clinical trials or intervention studies of drugs.

Outcomes

Primary Outcomes

In-hospital mortality

All-cause and cause-specific mortality will be described.

Time frame: 12 months

Readmission

Readmission rate caused by AECOPD within 1 month after discharged from hospital.

Time frame: 12 months

Secondary Outcomes

All-cause and cause-specific mortality

All-cause and cause-specific mortality will be described at different time points (1, 2, 3 years)

Time frame: 3 years

Recurrence of acute exacerbation of COPD

Frequency of AECOPD recurrence will be described during follow-ups, the date of first recurrence after discharge will be analysed.

Time frame: 3 years

Lung function and quality of life assessment

Lung function will be measured regularly, quality of life will be assessed by questionnaires

Time frame: 3 years

Healthcare costs

Direct costs of hospital stay will be recorded.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.